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work places was found. No signiﬁcant differences were found for other 
clinicopathological factors according to SHS exposure. 
Conclusions: Our results indicate weak evidence of relationship 
between likelihood of mutation in EGFR gene and SHS exposure. 
The deletion mutations in exon 19 were signiﬁcantly less common in 
patients with SHS exposure.
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Background: Lung carcinogenesis, is a multistage process involving 
alterations in multiple genes and diverse pathways. Inherited polymor-
phisms in a variety of genes, most notably the carcinogen metabolism, 
DNA repair and cell cycle control, may affect the susceptibility of an 
individual to develop lung cancer and prognosis, particularly in combi-
nation with environmental exposures. 
Methods: To comprehensively evaluate the impact of variation in the 
carcinogen metabolism, DNA repair and Cell cycle control pathway 
on lung cancer risk and prognosis, a hospital based case control study 
using 211 lung cancer patients and 211 healthy controls was carried out 
using polymerase chain reaction-restriction fragment length polymor-
phism assay. The distribution of each polymorphism among the cases 
and controls were determined and odds-ratios for the association of 
a particular polymorphism was analyzed using unconditional logistic 
regression model. Probability value at the <0.05 level of signiﬁcance 
was calculated. To assess the prognostic value of these SNPs, geno-
type- survival associations were also evaluated. The study subjects 
were followed up and overall survival was evaluated in Kaplan-Meier 
survival functions and Cox proportional hazards models. 
Results: The polymorphic deletions of the GSTM1 and GSTT1 genes 
was detected by PCR-based assays. PCR RFLP assays was used to 
genotype polymorphisms in GSTP1 (A1578G), CYP1A1 (T6235C), 
CYP2D6 (G1934A), XRCC1 (G28152A), XPD (A35931C ) and p53 
(Codon 72 C>G). Median age of patients was 59 years (Range, 20 to 84 
years) and in controls the median age was 57 years (Range 22-80 years) 
13.7% of patients were females compared to 12.8% in controls. Surviv-
al data were available for 170 (80%) patients. The risk prone genotypes 
were CYP1A1 TC (P=0.03*), CYP1A1 CC (P= .001*), GSTT1-/- ( 
P=0.001*), GSTP1 GG(P= 0.02*),CYP2D6 GA (P=0.04*),CYP2D6 
GG (P= 0.03*), XRCC1 399 AA (P=0.007*), XPD 751 AC (P=0.003*), 
p53 CC (P= 0.003*). Several of the genotype combinations involving 
came signiﬁcant in our study. Overall survival was determined from 
the time of LC diagnosis until death; patients alive or lost at follow-up 
were censored. Median survival time (MST) was 10 months and there 
were 66 deaths. Kaplan-Meier survival estimates for overall Survival 
revealed shorter overall survival for CYP1A1 (P=0.007*),CYP2D6 ( 
P=0.01*),GSTT1 null ( P=0.03*), XRCC1 399
(P=0.01*), p53 ( P=0.04*) respectively, by log-rank test. Multivari-
ate analysis using Cox Proportional Hazard model showed Signiﬁ-
cant Hazard Ratio for GSTT1-/- (HR=2.1, 95% CI: 1.158-4.116, 
P=0.01*),CYP1A1 CC (HR=2.3, 95% CI: 1.127-4.779, P=0.002*), 
XRCC1 399AA (HR=3.0, 95% CI: 1.393-6.670, P=0.005*), p53 codon 
72 CG (HR=2.2, 95% CI: 1.121-4.692), P=0.02*) and emerged as 
independent prognostic factors for overall survival. 
Conclusions: These ﬁndings suggest role of speciﬁc genetic variants in 
lung cancer susceptibility and that genetic polymorphisms may modu-
late overall lung cancer prognosis.
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Background: In the last 20 years lung cancer became the ﬁrst cause 
of death in women, exceeding also breast cancer. Many published retro-
spective studies suggest differences in the outcome between men and 
women as well as in terms of incidence and response to therapy. 
Patient and Methods: This is an Italian multicenter, prospective, 
consecutive case registration of patients (pts) with diagnosis of lung 
cancer. Starting from January 2006 we collected 100 cases of women 
(W) with newly diagnosis of lung cancer and we extrapolated from the 
database information collected in the same period of time about 100 
cases in men (M) adjusted for clinical stage and histotype. For women 
information about hormonal status was also collected. 
Results: With a minimal follow-up of six months the main patient 
characteristics are as follows: median age 60 years old (W =61, range 
40-85; M= 65, range 39-75), smokers 74% (W= 57%, M= 92%), PS 
0-1 91% (W= 75%, M= 98%), adenocarcinoma 44% (W= 48%, M= 
42%), squamous 14% (W= 16%, M= 13%), other NSCLC 29% (W= 
24%, M= 35%), SCLC 11% (W= 12%, M= 11%). Further information 
is summarized in the following table:
Histotype Stage Gender Surgery
Chemo-
therapy
Radio-
therapy
SCLC LD W 7% O 2% 7%
  M 7% O 2% 5%
 ED W 5% O O 5%
  M 5% O O 5%
NSCLC I-II W 19% 19% O 5%
  M 13% 13% O 1%
 IIIA W 9% 6% 2% 9%
  M 12% 8% 2% 12%
 IIIB W 12% 3% 3% 12%
  M 24% 3% 11% 23%
 IV W 48% O 10% * 48%
  M 39% 4% # 13% * 39%
#relapse after radical surgery; *palliative radiotherapy
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Among women 80% had children (47%>1 child), 13% reported a past 
history for oral contraceptive use, 85% were in postmenopausal period 
and 7% reported an hormonal replacement treatment for more than one 
month. 
Conclusion: The very preliminary data of this prospective data col-
lection, supported by WALCE, provide information about different 
aspects of lung cancer by gender, suggesting interesting hints about the 
necessity to collect accurate data about hormonal status in women with 
lung cancer.
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Background: Lung cancer is now one of the most frequently diag-
nosed cancer in the world and the incidence has increasing also in 
South Korea. In several recent studies, increasing incidence of adeno-
carcinoma and female/male ratio has been reported. The aim of this 
study is to investigate the changing trends in sex and age distribution 
the histological type of tumors in lung cancer.
Methods: The present retrospective study is based on the analysis of 
medical records of patients who diagnosed with primary lung cancer 
between 2000 and 2006 in Chungnam national university hospital. We 
analyzed the age and sex distribution, histological type and initial stage 
of lung cancer. 
Results: A total of 1341 cases were collected. The overall male to 
female ratio was 3.98: 1, and the age distribution ranged from 30 to 87 
years, and the median age of overall patients was 66 years. In 2000 the 
male/female ratio for lung cancer cases was 3.44:1, then with increas-
ing male rates and decreasing female rates, the ratio is now 5.41:1 in 
2006. Among 1341 patients, 69.9% (n=928) were current smokers and 
the rate of current smoking showed a signiﬁcant increasing trend over 
the years (68.0% in 2000, 76.0% in 2006, p=0.001). Squamous cell car-
cinoma (39.1%, n=523) was the leading type of lung cancer followed 
by adenocarcinoma (32.1%, n=430). The incidence of adenocarcinoma 
was more increased from 34.0% in 2000 to 37.4% in 2006 although 
squamous cell carcinoma remains the predominant type of lung cancer 
(36.0% in 2000, 41.2% in 2006). Advanced lung cancer, which was 
found in 64.2% of patients of non small cell lung cancer in 2000, in-
creased to 69.2% in 2006. But, rate of extended stage in small cell lung 
cancer decreased from 46.2% in 2000 to 35.0% in 2006.
Conclusion: In contrast to other countries, squamous cell carcinoma 
was still the most frequent type of lung cancer. But there has been a 
shift in the histology pattern with an increase in the percentage of ad-
enocarcinoma. High proportions of smoker and advanced, unresectable 
lung cancer urge us to develop the program for cessation of smoking 
and early detection.
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Cancer is on the second place as a death cause in the developed coun-
tries, and among the three leading causes in the developing countries.
Lung cancer(LC) in majority of the industriously developed countries is 
the most frequent in men.Immediately after lung, larynx cancer(LarC) 
comes according to the frequency of occurrence among respiratory 
tract cancers. The most important of the so called “lifestyle” risk fac-
tors in occurrence of the LC and LarC are cigarette smoking, while the 
endogenous ones are presented by psychosocial and genetic factor.
Objectives: To determine the distribution of LC and LarC cancer pa-
tients according to gender and age; to determine and quantify presence 
of smoking, heredity and stress in LC and LarC as well as to determine 
the importance of difference in presence of the mentioned risk factors 
between the two groups.
Methods: Investigation comprised the period from 1stJune 2005 up 
to 1stJune 2006, and included 35 LC and 35 LarC patients. Data were 
collected from the Clinical Centre. Descriptive and analytical epide-
miologic methods were applied.Structure percentage was determined in 
data analysis for the series with attributive features.Difference among 
the series with numerical features in independent specimens, was tested 
by t-test for independent specimens. Mann-Whitney U test was used 
to determine the signiﬁcance of difference between two independent 
specimens with attributive features.
Results: The group of LC patients comprised 28 (80%) men and 7 
(20%) women, while there were no women in the group of patients 
with LarC.Greatest percent of the diseased in both groups belonged 
to the age group from 50-69 years (68,6%-LC;80%-LarC).There 
was no signiﬁcant difference in the disease relating the genetic fac-
tor between the interviewees with LC and LarC for Z=0,23;p>0,05. 
Most frequent cancer localization in relatives of LC patients were 
the lungs(50%),nand in the relatives of the LarC patients was 
skin cancer(21,5%). There was no signiﬁcant difference (Z=-
1,5;p>0,05)between the LC and LarC in distribution of the malignant 
diseases concerning the cancer localization in relatives. Exposed to 
stressed situations were 54,3% persons with LC, 80% with LarC. For 
Z=2,27;p<0,05 stressed was signiﬁcantly more present among patients 
with LC than among those with LarC.For Z=0,6;p>0,05 there was 
no signiﬁcant difference in relation to stress type (acute or chronic) 
between the diseased from both cancers.Cigarette smoking habit was in 
a great extent present among the diseased:LC-54,3%;LarC-68,6%. Ma-
jority of the diseased smoke between 21-40 cigarettes per day (48,4%-
LC;62,9%-LarC). There was no signiﬁcant difference in the number 
of the daily smoked cigarettes between the diseased LC patients and 
those with LarC(Z=-0,58;p>0,05). Smoking length from 31-45 years 
had the greatest percent of the participants in the both groups (41,9%-
LC;51,4%-LarC).
Conclusions: Results from this study proved the role of smoking as 
the most important risk factor in the occurrence of the LC and LarC.
M ain stress in prevention of these diseases has been directed towards 
information of the population about harmful effects of this habit. 
